Cardiac preconditioning: myths and mysteries Enjarn Lin May 2011.

Slides:



Advertisements
Similar presentations
Peri-operative cardiac protection
Advertisements

Off pump CABG has been performed for the first time 40 years ago. Although conventional CABG is considered both safe and effective, the use of CBP.
Protection Devices in PCI-Treatment of Myocardial Infarction for Salvage of Endangered Myocardium Study Presented at American College of Cardiology Scientific.
Post-conditioning the human heart to reduce infarct size
Postconditioning: A new link in nature’s armor against myocardial ischemia/reperfusion injury Gao Qin
Cyclosporine A reduces infarct size and has no detrimental effect of LV remodeling in STEMI patients Michel Ovize Cardiology Hospital and Inserm U886 Lyon.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist,
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Biochemical Markers of Myocardial Infarction
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Management of Stable Angina SIGN 96
Coronary Artery Disease in Diabetic Patients, Different from Non-diabetics?
M Ruel, V Chan, M Boodhwani, B McDonald, X Ni, G Gill, K Lam, F Rubens, P Hendry, R Masters, T Mesana Ottawa, Canada How Detrimental is Re-Exploration.
Ischemia-Reperfusion injury Su Chang Fu 90/6/19. Ischemia Anesthesiologist: MI, peripheral vascular insufficiency, stroke, and hypovolemic shock Restoration.
Role of Adenosine Receptor in Ischemic Preconditioning.
Myocardial preconditioning Joel Starkopf Departement of Anaesthesiology and Intensive Care University of Tartu Estonia.
Differential regulation of calcium regulatory proteins between sevoflurane postconditioning and delayed remote ischemic preconditioning in an isolated.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Remote Ischemic Conditioning: An Update on Mechanisms Remote Ischemic Conditioning: An Update on Mechanisms Karin Przyklenk PhD Director, Cardiovascular.
Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty Study (ARMYDA-2) Trial ARMYDA-2 Trial Presented at The American College of Cardiology.
Minimise the damage – Pre- and Post-conditioning Dr Derek J Hausenloy The Hatter Cardiovascular Institute, University College London, UK. Myocardial Recovery.
S Reducion of infarction size as a target Mohamed Mahmoud Abd El Ghany Mohamed Mahmoud Abd El Ghany Cardiology Professor of Cairo University.
Diabetes and Myocardial Ischaemia - Sensitivity of the diabetic heart to ischemic injury.
Can we protect patients undergoing percutaneous coronary intervention better? Beneficial effects of short- and long-term trimetazidine MR therapy in patients.
Biochemical Investigations In Heart Disaeses
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Ischaemic Heart Disease CASE A. CASE A: Mr HA, aged 60 years, was brought in to A&E complaining of chest pain, nausea and a suspected AMI.
Ischemic Conditioning and Endothelial Function Todd Anderson Libin Cardiovascular Institute University of Calgary.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Can we better protect patients who undergo revascularization? Beneficial effects of short- and long-term trimetazidine MR therapy in patients undergoing.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Myocardial Infarction (MI) Prepared by Miss Fatima Hirzallah RNS, MSN,CNS.
Lund – Malmö, SWEDEN. Is the Era of Off-pump Surgery over? ARASH MOKHTARI, MD, PHD.
Gender differences in AMPK activation in the heart and white quadriceps muscle following exercise training in mice. Matthew Peterson Supervisor: Dr. Paul.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
INTRODUCTION: Post operative pulmonary hypertension (PH) complicates 2 % of patients undergoing cardiac surgery with pulmonary hypertensive crises (PHC)
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
CRT 2015 Unmet Needs in STEMI Interventions
Jeff Macemon MBChB, PDMSM Advanced Trainee, CTS
Damian Gimpel Waikato Cardiothoracic Unit
Biochemical Investigations In Heart Disaeses
Cardiac enzymes. 2 – Non enzyme proteins The Troponins
CABG in diabetics: surgical aspects
Ischemic conditioning –Evidence review
Successful CTO PCI Associated with Lower Mortality Risk
Previous Relative Trials
Balloon-pump assisted Coronary Intervention Study (BCIS-1):
Mortality Related to Periprocedural MI in CTO-PCI
RAAS Blockade: Focus on ACEI
Cardiovacular Research Technologies
Jeff Macemon Waikato Cardiothoracic Unit
The mechanisms of cardio-protective effects of desflurane and sevoflurane at the time of reperfusion: anaesthetic post-conditioning potentially translatable.
European Heart Association Journal 2007 April
European Society of Cardiology 2003
Figure 2 Signalling pathways of ischaemic conditioning
Myocardial ischaemia reperfusion injury: the challenge of translating ischaemic and anaesthetic protection from animal models to humans  Z. Xia, H. Li,
Preventive Angioplasty in Myocardial Infarction Trial
Global Registry of Acute Coronary Events: GRACE
Figure 1 Ischaemic conditioning
Biochemical Markers of Myocardial Infarction
Hypothermia in awake STEMI patients:
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Cardiac preconditioning: myths and mysteries Enjarn Lin May 2011

Introduction  Perioperative myocardial infarction is associated with prolonged hospital stay & increased mortality  Identify at risk patients  Institute therapeutic strategies  coronary revascularisation  β-blockade  α 2 -adrenoceptor agonists  aspirin & statins  prayer

 US Multicentre RCT  1802 patients undergoing CABG  Randomised to 3 groups:  Uncertain but received prayer  Uncertain & did not receive prayer  Certain & received prayer

Intercessory prayer  No effect on complication-free recovery from CABG  Intercessory prayer had a higher incidence of complications.

Ischaemia-reperfusion injury  ATP depletion  Accumulation of H +  Na + & Ca 2+ influx

Ischaemia-reperfusion injury  Rapid normalisation of pH  Ca 2+ /ROS  Opening of mitochondrial permeabilitytransition pore (mPTP)  Uncoupling of oxidative phosphorylation

Goals of myocardial protection 1. Limit the duration and extent of ischaemia 2. Ensure the adequacy of timely reperfusion 3. Modify the cellular responses to ischaemia- reperfusion injury 4. Cardiac conditioning

Ischaemic Preconditioning  4 cycles of 5 minute ischaemia with intermittent reperfusion prior to coronary occlusion  Subsequent infarct size 75% smaller than controls

 22 RCT’s 933 patients  On pump patients received cardioplegia or ICCF  Variable IPC protocols  Pooled analysis:  No difference in mortality or perioperative MI  Significant reductions in ventricular arrhythmias, inotrope use & ICU length of stay

Ischaemic PostConditioning  Conditioning stimulus applied after onset of myocardial ischaemia during reperfusion period  Similar ability to attenuate the detrimental effects of IRI as IPC.  Strategy to improve outcome from evolving myocardial infarction

Ischaemic postconditioning in cardiac surgery StudyPatient groupStimulusOutcomesNumber Luo 2007Repair Tetralogy of FallotAortic clamping (2 cycles of 5 min) Less troponin I release24 Luo 2008Valve surgery(cold-blood cardioplegia) Aortic clamping (3 cycles of 5 min) Reduced CK-MB No change to troponin I Less inotropic support 50 Luo 2008Congenital heart disease(cold-blood cardioplegia) Aortic clamping (2 cycles of 5 min) Less troponin I release Less inotropic support 40

 6 RCTs, 244 patients presenting with STEMI undergoing primary PCI  Significant reduction in peak CK & improved LV performance  Intervention benefit over standard care

Clinical Applicability  Clinical benefits limited :  Cardiology & cardiothoracic surgery  Transplantation  Inducing ischaemia in an already diseased target organ

‘Preconditioning at a distance’  Brief episodes of ischaemia & reperfusion in LCx territory reduced size of a subsequent infarct due to occlusion of LAD coronary artery  Magnitude of ischaemic protection similar to direct ischaemic preconditioning  Extended to non cardiac organs: kidney, small intestine, brain & skeletal muscle  Remote ischaemic preconditioning or ischaemic preconditioning at a distance

Conditioning the myocardium IschaemiaReperfusion PostCon ReperfusionIschaemia PreCon Brief ischaemia remotely or locally ReperfusionIschaemia PerCon Remote ischaemia

Activation via G-protein couple receptor Mitogen-activated protein kinases Pro-survival protein kinases Mitochondrial K ATP channel Mitochondrial permeability Transition pore (mPTP)

The end effectors? mitochondrial K ATP channel:  Implicated as critical mediator  Sulphonylureas abolish IPC  Maintains Ca 2+ homeostasis  Interaction with mPTP unclear mitochondrial permeability transition pore:  Non-specific high conductance channel  Opening uncouples oxidative phosphorylation & ATP depletion  Prevention of opening underpins IPC/RIPC

Clinical trials in RIC StudyJournalPatient groupStimulusOutcomesNumber Cheung (2006)JACCPaediatric cardiac surgery Upper-limb ischaemia (4 cycles of 5 min) Reduced troponin; reduced inotrope score; reduced airway resistance 37 Hausenloy (2007) LancetCABGUpper-limb ischaemia (3 cycles of 5 min) Reduced troponin57 Ali (2007)CirculationAAA surgeryLower-limb ischaemia (2 cycles of 10 min) Reduced troponin; reduced perioperative MI; preserved renal function 82 Hoole (2009)CirculationElective coronary angioplasty Upper-limb ischaemia (3 cycles of 5 min) Reduced troponinI ; reduced MACCE 242 Venugopal (2009) HeartCABG (cold-blood cardioplegia) Upper-limb ischaemia (3 cycles of 5 min) Reduced troponin45 Botker (2009)LancetPrimary coronary angioplasty (STEMI) Upper-limb ischaemia (3 cycles of 5 min) Increased myocardial salvage; decreased infarct size at 1 month 333

Pharmacological preconditioning StudyPatient groupDrugOutcomesNumber Mangano 2006CABGAcadesine (adenosine modulator) No difference in MI2698 Kitakaze 2007STEMIAtrial Natriuretic Peptide and Nicorandil ANP: decreased infarct size & improved LV function Nicorandil: No difference 1216 Mentzer 2008CABGCariporide (Na + /H + exchange inhibitor) Decreased MI Increased CVA 5761

Opioid preconditioning  Opioids (via δ&κ receptors) can trigger cardiac preconditioning; naloxone blocks preconditioning  Cardiomyocytes sites of endogenous opioid synthesis, storage and release  Opioids act as autocoids, released during times of stress & ischaemia  Open the K ATP channel & close the mPTP.

 46 patients undergoing CABG randomised to morphine or fentanyl before CPB  No difference in BNP or troponin  Morphine improved LV function  40 patients randomised to receive remifentanil bolus & infusion prior to sternotomy  Primary outcome troponin I reduced  Shorter mechanical ventilation time

Volatile anaesthetic preconditioning  Volatile anaesthetics can protect the myocardium  Volatile anaesthetics can similarly precondition/postcondition the myocardium  Similar mechanistic pathways as ischaemic conditioning  Evidence of volatile anaesthetic late preconditioning

Clinical trials with volatile anaesthetics  Randomized 200 patients undergoing CABG to 4 anaesthetic protocols 1. Propofol TIVA 2. Sevoflurane from sternotomy to CPB 3. Sevoflurane after coronary anastomosis 4. Sevoflurane from sternotomy  Compared to TIVA, continuous Sevoflurane significantly reduced troponin I leakage for the first 48 hours

 22 RCTs identified, 1922 patients undergoing cardiac surgery, all too small to report on mortality  Predominantly undergoing on-pump CABG, 6 RCTs of OPCAB, 1 of mitral surgery  Majority had volatile throughout; 6 had volatile only before or during expected period of ischaemia  Dosage: Desflurane MAC & Sevoflurane MAC

Landoni et al   enzyme leak   inotrope requirement   mechanical ventilation time   ICU length of stay   hospital length of stay   MI   all cause mortality

PostConditioning  58 patients with STEMI  IV cyclosporine (non specific mPTP blocker) prior to PCI  Reduction in enzyme leakage  Significant reduction in infarct size assessed by cardiac MRI

RCTs in conditioning for IRI  >50 ischaemic conditioning  Predominately RIC  >40 pharmacological preconditioning  Predominately volatile anaesthesia

Conclusions  Brief ischaemia is good/prolonged ischaemia is bad  Anaesthesia is good for you!  Larger trials are required  Praying for our patients doesn’t appear to improve outcomes